COMPETE: a phase III trial of 177Lu-edotreotide vs everolimus in patients with progressive, SSTR-positive GEP-NETs - Capdevila, J; Borbath, I; Pavel, M
Presented at: ENETS 2025 Annual Conference; March 6, 2025; Krakow, Poland